Literature DB >> 6611927

Primary lower extremity lymphedema: CT diagnosis.

J L Gamba, P M Silverman, D Ling, N R Dunnick, M Korobkin.   

Abstract

The CT findings of two cases of primary lymphedema of the lower extremities are presented. CT showed a coarse, nonenhancing, reticular pattern in an enlarged subcutaneous compartment. CT excluded the diagnosis of secondary lymphedema from an obstructing mass by demonstrating a normal retroperitoneum and pelvis. The CT findings are correlated with pedal lymphangiograms.

Entities:  

Mesh:

Year:  1983        PMID: 6611927     DOI: 10.1148/radiology.149.1.6611927

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

1.  Case report 861: Primary lymphedema of the left lower extremity.

Authors:  A Huang; A Fruauff; F DiCarmine; A Schuss; R Losada; L Goffner
Journal:  Skeletal Radiol       Date:  1994-08       Impact factor: 2.199

2.  CT analysis of the use of the electrical impedance technique to estimate local oedema in the extremities in patients with lymphatic obstruction.

Authors:  R Watanabe; H Kotoura; Y Morishita
Journal:  Med Biol Eng Comput       Date:  1998-01       Impact factor: 2.602

3.  A Novel Way of Standardization of ICG Lymphangiography Reporting.

Authors:  Ashok Basur Chandrappa; Ritu Batth; Srikanth Vasudevan; Anantheswar Yellambalase N; Dinkar Sreekumar
Journal:  Indian J Plast Surg       Date:  2020-11-19

4.  Deep learning-based quantitative estimation of lymphedema-induced fibrosis using three-dimensional computed tomography images.

Authors:  Kyo-In Koo; Chang Ho Hwang; Hyewon Son; Suwon Lee; Kwangsoo Kim
Journal:  Sci Rep       Date:  2022-09-13       Impact factor: 4.996

5.  Comparison of a novel algorithm quantitatively estimating epifascial fibrosis in three-dimensional computed tomography images to other clinical lymphedema grading methods.

Authors:  Kyo-In Koo; Myoung-Hwan Ko; Yongkwan Lee; Hye Won Son; Suwon Lee; Chang Ho Hwang
Journal:  PLoS One       Date:  2019-12-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.